• Views: in the last
  • 28Week
  • 19Month
  • 227Total


  • NJ A620
  • Requires health care practitioners to discuss risk of addiction when prescribing certain drugs to patients who are minors.
Introduced
(1/27/2016)
In Committee
(1/27/2016)
Crossed OverPassedSignedDead/Failed/Vetoed
2016-2017 Regular Session
This bill requires health care practitioners to discuss the addiction potential of certain drugs prior to issuing a prescription for the drug to a patient who is under 18 years of age. The practitioner will have this discussion with the patient, if the patient is an emancipated minor, and with the patient's parent or guardian, if the patient is not an emancipated minor. The bill applies to Schedule II controlled dangerous substances and any prescription opioid drug, and practitioners are required to discuss the risk of developing a physical or psychological dependence on the substance or drug. Practitioners will also have discretion to discuss such alternative treatments as may be available. The practitioner will be required to obtain, and include in the patient's medical record, written acknowledgement that the discussion took place using a form which is to be developed by the Division of Consumer Affairs in the Department of Law and Public Safety in consultation with such medical professional societies and associations as may be designated by the Director of the Division of Consumer Affairs. The division will also be required to develop and make available to practitioners guidelines for the discussion required under the bill. The provisions of the bill will not apply to a patient who is currently receiving hospice care from a licensed hospice.
Health and Senior Services
Introduced, Referred to Assembly Health and Senior Services Committee  (on 1/27/2016)
 
 

Date Chamber Action Description
1/27/2016 A Introduced, Referred to Assembly Health and Senior Services Committee
Date Motion Yea Nay Other
None specified